Back to News
Market Impact: 0.2

Notable Tuesday Option Activity: TDOC, BSX, TRIP

BSXTRIP
Futures & OptionsDerivatives & VolatilityCompany FundamentalsMarket Technicals & FlowsHealthcare & BiotechTravel & Leisure
Notable Tuesday Option Activity: TDOC, BSX, TRIP

Boston Scientific (BSX) and Tripadvisor (TRIP) experienced notable options trading volume, with BSX seeing 28,191 contracts traded, particularly for the $90 strike put option expiring June 2025, and TRIP seeing 11,536 contracts traded, especially for the $13 strike put option expiring January 2026; these volumes represent approximately 41% and 40.4% of their respective average daily trading volumes over the past month, suggesting increased investor activity in these specific options.

Analysis

Boston Scientific (BSX) and Tripadvisor (TRIP) both experienced significant options trading activity on the reporting day. BSX recorded a total options volume of 28,191 contracts, equivalent to approximately 2.8 million underlying shares, which constitutes about 41% of its average daily trading volume of 6.9 million shares over the past month. Notably, 19,631 of these contracts were for the $90 strike put option expiring June 20, 2025, representing nearly 2.0 million underlying BSX shares. Concurrently, Tripadvisor (TRIP) saw 11,536 options contracts traded, translating to roughly 1.2 million underlying shares, or 40.4% of its month-long average daily volume of 2.9 million shares. Within TRIP's options, 5,042 contracts were traded for the $13 strike put option expiring January 16, 2026. This concentrated daily trading volume in specific put options for both companies suggests heightened investor focus, potentially indicating expectations of price declines below these strike levels, strategic hedging against existing long positions, or significant speculative bets. The neutral sentiment score (0.0) of the report underscores that this is a factual observation of market activity.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo